Treatment of anemia with darbepoetin alfa in systolic heart failure | ||
| dc.conicet.organizacion | University of Gothenburg | |
| dc.conicet.organizacion | Cleveland Clinic | |
| dc.conicet.organizacion | University of Minnesota | |
| dc.conicet.organizacion | Amgen | |
| dc.conicet.organizacion | Brigham and Women’s Hospital | |
| dc.conicet.organizacion | Estudios Clínicos Latinoamérica | |
| dc.conicet.organizacion | Italian Association of Hospital Cardiologists Research Center | |
| dc.conicet.organizacion | University of Glasgow | |
| dc.conicet.organizacion | University of Duke | |
| dc.conicet.organizacion | Brigham and Women’s Hospital | |
| dc.conicet.organizacion | Brigham and Women’s Hospital | |
| dc.conicet.organizacion | Amgen | |
| dc.conicet.organizacion | Medical University of Silesia | |
| dc.conicet.organizacion | University of Groningen | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.contributor.author | Swedberg, Karl | |
| dc.contributor.author | Young, James B. | |
| dc.contributor.author | Anand, Inder S. | |
| dc.contributor.author | Cheng, Sunfa | |
| dc.contributor.author | Desai, Akshay S. | |
| dc.contributor.author | Diaz, Rafael | |
| dc.contributor.author | Maggioni, Aldo P. | |
| dc.contributor.author | McMurray, John J.V. | |
| dc.contributor.author | O’Connor, Christopher | |
| dc.contributor.author | Pfeffer, Marc A. | |
| dc.contributor.author | Solomon, Scott D. | |
| dc.contributor.author | Sun, Yan | |
| dc.contributor.author | Tendera, Michal | |
| dc.contributor.author | van Veldhuisen, Dirk J. | |
| dc.contributor.author | Toblli, Jorge Eduardo | |
| dc.date.issued | 2013-03 | |
| dc.description.abstract | BACKGROUND: Patients with systolic heart failure and anemia have worse symptoms, functional capacity, and outcomes than those without anemia. We evaluated the effects of darbepoetin alfa on clinical outcomes in patients with systolic heart failure and anemia. METHODS: In this randomized, double-blind trial, we assigned 2278 patients with systolic heart failure and mild-to-moderate anemia (hemoglobin level, 9.0 to 12.0 g per deciliter) to receive either darbepoetin alfa (to achieve a hemoglobin target of 13 g per deciliter) or placebo. The primary outcome was a composite of death from any cause or hospitalization for worsening heart failure. RESULTS: The primary outcome occurred in 576 of 1136 patients (50.7%) in the darbepoetin alfa group and 565 of 1142 patients (49.5%) in the placebo group (hazard ratio in the darbepoetin alfa group, 1.01; 95% confidence interval, 0.90 to 1.13; P=0.87). There was no significant between-group difference in any of the secondary outcomes. The neutral effect of darbepoetin alfa was consistent across all prespecified subgroups. Fatal or nonfatal stroke occurred in 42 patients (3.7%) in the darbepoetin alfa group and 31 patients (2.7%) in the placebo group (P=0.23). Thromboembolic adverse events were reported in 153 patients (13.5%) in the darbepoetin alfa group and 114 patients (10.0%) in the placebo group (P=0.01). Cancer-related adverse events were similar in the two study groups. CONCLUSIONS: Treatment with darbepoetin alfa did not improve clinical outcomes in patients with systolic heart failure and mild-to-moderate anemia. Our findings do not support the use of darbepoetin alfa in these patients. (Funded by Amgen; RED-HF ClinicalTrials.gov number, NCT00358215.). | es |
| dc.description.fil | Fil: Swedberg, Karl. University of Gothenburg; Suecia | |
| dc.description.fil | Fil: Young, James B.. Cleveland Clinic; Estados Unidos | |
| dc.description.fil | Fil: Anand, Inder S.. University of Minnesota; Estados Unidos | |
| dc.description.fil | Fil: Cheng, Sunfa. Amgen; Estados Unidos | |
| dc.description.fil | Fil: Desai, Akshay S.. Brigham and Women’s Hospital; Estados Unidos | |
| dc.description.fil | Fil: Diaz, Rafael. Estudios Clínicos Latinoamérica; Argentina | |
| dc.description.fil | Fil: Maggioni, Aldo P.. Italian Association of Hospital Cardiologists Research Center; Italia | |
| dc.description.fil | Fil: McMurray, John J.V.. University of Glasgow; Reino Unido | |
| dc.description.fil | Fil: O’Connor, Christopher. University of Duke; Estados Unidos | |
| dc.description.fil | Fil: Pfeffer, Marc A.. Brigham and Women’s Hospital; Estados Unidos | |
| dc.description.fil | Fil: Solomon, Scott D.. Brigham and Women’s Hospital; Estados Unidos | |
| dc.description.fil | Fil: Sun, Yan. Amgen; Estados Unidos | |
| dc.description.fil | Fil: Tendera, Michal. Medical University of Silesia; Polonia | |
| dc.description.fil | Fil: van Veldhuisen, Dirk J.. University of Groningen; Países Bajos | |
| dc.description.fil | Fil: Toblli, Jorge Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Swedberg, Karl; Young, James B.; Anand, Inder S.; Cheng, Sunfa; Desai, Akshay S.; et al.; Treatment of anemia with darbepoetin alfa in systolic heart failure; Massachusetts Medical Soc; New England Journal Of Medicine; 368; 3-2013; 1210-1219 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0028-4793 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/24327 | |
| dc.journal.ciudad | Massachusetts | es |
| dc.journal.pagination | 1210-1219 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | New England Journal Of Medicine | es |
| dc.journal.volume | 368 | es |
| dc.language.iso | eng | es |
| dc.publisher | Massachusetts Medical Soc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1056/NEJMoa1214865 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://www.nejm.org/doi/full/10.1056/NEJMoa1214865 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Systolic Heart Failure | es |
| dc.subject | Anemia | es |
| dc.subject | Darbepoetin | es |
| dc.subject.classification | Ética Médica | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Treatment of anemia with darbepoetin alfa in systolic heart failure | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.aeb5865d-30a7-4ad5-a6b6-3cfa4c79d72f_A.pdf
- Tamaño:
- 653.02 KB
- Formato:
- Adobe Portable Document Format